Premium
Radiation‐killed BCG in the treatment of transplanted rat tumours
Author(s) -
Baldwin R. W.,
Cook A. J.,
Hopper D. G.,
Pimm M. V.
Publication year - 1974
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910130602
Subject(s) - medicine , immunotherapy , immunity , bcg vaccine , sarcoma , radiation therapy , cancer research , immunology , immune system , pathology , vaccination , surgery
Growth of syngeneic transplants of methylcholanthrene‐induced sarcomas and an aminoazo‐dye‐induced hepatoma in rats was suppressed when tumour cells were injected in admixture with BCG vaccine containing living organisms, or vaccine sterilized by exposure to 1 to 3 × 10 6 R γ‐irradiation. Rejection of mixed inocula containing viable or radiation‐killed BCG induced immunity to further challenge with tumour cells. Also pulmonary tumour growth produced by intravenous injection of sarcoma cells was controlled by intravenous injection of living or radiation‐killed BCG. These studies indicate that radiation‐sterilized preparations may replace viable vaccine in immuno‐therapy, at least where tumour suppression results from contact with BCG. The use of sterilized vaccine in comparable clinical situations would remove any danger of the generalized BCG infection which has recently been reported in patients receiving BCG immunotherapy.